SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

UBS Cuts Axsome Therapeutics Price Target to $239 From $256

Valid market news retained in the public archive without immediate LiveCast distribution.

AXSM

Related stories